Clinical Trial Update: Extended Access Program of Vedolizumab IV in Ulcerative Colitis and Crohn's Disease [Phase 4]

View source ↗

Summary

Phase 4 extended access trial of vedolizumab IV in ulcerative colitis and Crohn's disease has been terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• Vedolizumab (vedolizumab)

Snippet

Sponsor: Takeda | Conditions: Colitis, Ulcerative, Crohn Disease | Phase 4 | Status: TERMINATED | Results posted: 2023-11-18